Glucose-lowering therapy in patients undergoing percutaneous coronary intervention
- 1 October 2021
- journal article
- review article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 17 (8) , e618-e630
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 99 references indexed in Scilit:
- Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetesDiabetes & Metabolism, 2013
- TrialogueActa Diabetologica, 2013
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Effect of Glucose—Insulin—Potassium Infusion on Mortality in Critical Care Settings: A Systematic Review and Meta‐AnalysisThe Journal of Clinical Pharmacology, 2009
- Intensive versus Conventional Glucose Control in Critically Ill PatientsNew England Journal of Medicine, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Incidence and Risk Factors for Stroke in Type 2 Diabetic PatientsStroke, 2007
- Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous StrokeStroke, 2007
- The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI studyDiabetic Medicine, 2004
- Lactic Acidosis in Patients with Diabetes Treated with MetforminNew England Journal of Medicine, 1998